P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma
Diseases of the Esophagus · 22.08.2026 · 39 (Supplement_1)
DOI: 10.1093/dote/doag077.253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 22.08.2026. Verfasst von Laurie Clauzon und 7 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Topic Esophageal Cancer: Molecular Biology/Pathology Background Resistance to perioperative FLOT chemotherapy remains a major determinant of poor outcome in esophageal adenocarcinoma. Epithelial–mesenchymal plasticity (EMP) enables dynamic cell state transitions that may promote adaptive chemoresistance, yet its functional contribution to chemoresistance in esophageal adenocarcinoma remains insufficiently characterized.
Methods
Esophageal adenocarcinoma cell models were engineered to stably express a dual-fluorescent reporter system driven by E-cadherin and vimentin promoters, allowing real-time visualization of epithelial, mesenchymal, and hybrid epithelial/mesenchymal (E/M) states. Fluorescence-Activated Cell Sorting was used to isolate phenotypically distinct subpopulations. Sensitivity to FLOT chemotherapy was assessed using cell viability and clonogenic survival. Dynamic state transitions were evaluated following chemotherapy exposure. RNA sequencing on sorted populations will enable the identification of transcriptional programs associated with chemoresistance and EMP.
Results
Distinct epithelial–mesenchymal subpopulations were identified across several cellular models, with marked heterogeneity. One model, FLO1, exhibited all three phenotypic states, including a hybrid E/M population indicative of high plasticity. FLOT chemotherapy exposure induced significant phenotypic shifts toward hybrid states, accompanied by increased survival and persistence of this cell subset. These findings suggest a dynamic, reversible model of chemoresistance driven by EMP rather than fixed cell identity.
Conclusion
Epithelial–mesenchymal plasticity promotes adaptive resistance to FLOT chemotherapy in esophageal adenocarcinoma by enabling dynamic transitions toward therapy-tolerant states. Defining molecular programs underlying these transitions may support the development of treatment strategies that limit resistance and improve patient response to perioperative chemotherapy.
Zitieren
APA
Clauzon, L., SHAMS, K., DRAGO, R., CUCCHIARA, M., Blangé, D., Bijlsma, M., FRANCO, S. D. I., & STASSI, G. (2026). P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma. Diseases of the Esophagus, 39(Supplement_1). https://doi.org/10.1093/dote/doag077.253
Vancouver
Clauzon L, SHAMS K, DRAGO R, CUCCHIARA M, Blangé D, Bijlsma M, et al. P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma. Diseases of the Esophagus. 2026;39(Supplement_1). doi:10.1093/dote/doag077.253
BibTeX
@article{Clauzon2026,
author = {Clauzon, Laurie and SHAMS, Kimiya and DRAGO, Roberta and CUCCHIARA, Martina and Blangé, Dionne and Bijlsma, Maarten and FRANCO, Simone D I and STASSI, Giorgio},
title = {P1.105. Epithelial–Mesenchymal Plasticity Underlies Adaptive Resistance to FLOT Chemotherapy in Esophageal Adenocarcinoma},
journal = {Diseases of the Esophagus},
year = {2026},
volume = {39},
number = {Supplement_1},
doi = {10.1093/dote/doag077.253}
}
EUVIMED